Medtronic buys patch pump shares

Medtronic plans to integrate its new insulin dosing algorithm, which is used in the 780G pump, with EOFlow’s pump and is offering to buy all outstanding shares of EOFlow,

EOFlow’s technology currently is authorized in Europe, South Korea, Indonesia and the United Arab Emirates, with a smartphone application that allows users to monitor and control the patch directly from their phone.

EOFlow’s founder Jesse Kim said that the transaction would accelerate the company’s next phase of growth: “With a global footprint in over 100 countries, ability to scale up manufacturing quickly, and advanced software and sensor capabilities, Medtronic is the ideal strategic partner for EOFlow.”

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).